Haemophilus Influenzae Type
📧 Sign up to get email alerts when something new happens for Haemophilus Influenzae Type.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth [Phase 3]
Phase 3 trial update evaluating the immunogenicity and safety of Sanofi Pasteur's combined vaccine given as a three-dose primary series in i…
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. [Phase 3]
Phase 3 safety study evaluating a vaccine against meningitis in infants following a birth dose of hepatitis B; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age [Phase 2]
Phase 2 immunogenicity and safety study of GSK's GSK2202083A vaccine in healthy infants aged 2, 3, and 4 months completed.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants [Phase 4]
Phase 4 trial updating safety and reactogenicity of DTPa-IPV/Hib vaccine administered at 3, 4, 5 and 18 months in healthy infants; completed…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants [Phase 4]
Phase 4 trial update on immunogenicity and safety of Infanrix Hexa in infants, with results posted after completion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course [Phase 4]
Phase 4 trial comparing immunogenicity and reactogenicity of INFANRIX HEXA and INFANRIX HEXAVAC as a primary vaccination course; completed s…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers [Phase 3]
A Phase 3 trial comparing Pediacel to Infanrix-IPV+Hib when co-administered with Prevenar in infants and toddlers has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) [Phase 2]
Phase 2 trial assessing safety and immunogenicity of booster doses for new formulations of GSK's DTPa-HBV-IPV/Hib vaccine (GSK217744) in chi…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers [Phase 3]
Phase 3 safety trial of Infanrix-IPV+Hib vaccine in healthy Vietnamese toddlers completed with results posted
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants [Phase 2]
Phase 2 trial comparing a DTaP-IPV-Hep B-PRP~T combined vaccine with PENTAXIM and ENGERIX B in Argentinean infants has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine [Phase 3]
Phase 3 trial update on the immunogenicity and safety of Infanrix-IPV+Hib vaccine from GlaxoSmithKline, completed with posted results in 201…
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants [Phase 3]
This Phase 3 trial compares ACTACEL (DTaP-PRP-T) with separate DTaP and Act-HIB vaccines in healthy infants and has completed.
-
CLINICAL_TRIALS trial_result · 2009-06-25Clinical Trial Update: Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine [Phase 4]
Phase IV study evaluating interchangeability of a liquid pentavalent combination vaccine for diphtheria, tetanus, pertussis, hepatitis B, an…
-
CLINICAL_TRIALS trial_result · 2009-06-25Clinical Trial Update: Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine [Phase 4]
Phase 4 safety and immunogenicity assessment of a liquid pentavalent DTP-HepB-Hib vaccine completed.